Does LENALIDOMIDE Cause Rectal adenocarcinoma? 55 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 55 reports of Rectal adenocarcinoma have been filed in association with LENALIDOMIDE (LENALIDOMIDE). This represents 0.0% of all adverse event reports for LENALIDOMIDE.
55
Reports of Rectal adenocarcinoma with LENALIDOMIDE
0.0%
of all LENALIDOMIDE reports
9
Deaths
17
Hospitalizations
How Dangerous Is Rectal adenocarcinoma From LENALIDOMIDE?
Of the 55 reports, 9 (16.4%) resulted in death, 17 (30.9%) required hospitalization, and 11 (20.0%) were considered life-threatening.
Is Rectal adenocarcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LENALIDOMIDE. However, 55 reports have been filed with the FAERS database.
What Other Side Effects Does LENALIDOMIDE Cause?
Diarrhoea (27,576)
Fatigue (22,956)
Death (19,213)
Off label use (17,017)
Rash (15,794)
Pneumonia (14,807)
Plasma cell myeloma (14,191)
Neuropathy peripheral (10,215)
White blood cell count decreased (9,996)
Constipation (9,635)
What Other Drugs Cause Rectal adenocarcinoma?
DEXAMETHASONE (46)
BEVACIZUMAB (40)
ADALIMUMAB (39)
FLUOROURACIL (36)
OXALIPLATIN (34)
LEUCOVORIN (27)
ETANERCEPT (25)
INFLIXIMAB (25)
PANITUMUMAB (22)
METHOTREXATE (21)
Which LENALIDOMIDE Alternatives Have Lower Rectal adenocarcinoma Risk?
LENALIDOMIDE vs LENIOLISIB
LENALIDOMIDE vs LENOGRASTIM
LENALIDOMIDE vs LENVATINIB
LENALIDOMIDE vs LEPONEX
LENALIDOMIDE vs LERCANIDIPINE